These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37992218)

  • 1. Survival in primary hemophagocytic lymphohistiocytosis, 2016 to 2021: etoposide is better than its reputation.
    Böhm S; Wustrau K; Pachlopnik Schmid J; Prader S; Ahlmann M; Yacobovich J; Beier R; Speckmann C; Behnisch W; Ifversen M; Jordan M; Marsh R; Naumann-Bartsch N; Mauz-Körholz C; Hönig M; Schulz A; Malinowska I; Hines M; Nichols KE; Gil-Herrera J; Talano JA; Crooks B; Formankova R; Jorch N; Bakhtiar S; Kühnle I; Streiter M; Nathrath M; Russo A; Dürken M; Lang P; Lindemans C; Henter JI; Lehmberg K; Ehl S
    Blood; 2024 Mar; 143(10):872-881. PubMed ID: 37992218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study.
    Bergsten E; Horne A; Aricó M; Astigarraga I; Egeler RM; Filipovich AH; Ishii E; Janka G; Ladisch S; Lehmberg K; McClain KL; Minkov M; Montgomery S; Nanduri V; Rosso D; Henter JI
    Blood; 2017 Dec; 130(25):2728-2738. PubMed ID: 28935695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of pediatric primary hemophagocytic lymphohistiocytosis with the HLH-94/2004 regimens and hematopoietic stem cell transplantation in China.
    Ma H; Zhang R; Zhang L; Wei A; Zhao X; Yang Y; Liu W; Li Z; Qin M; Wang T
    Ann Hematol; 2020 Oct; 99(10):2255-2263. PubMed ID: 32766934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ruxolitinib-based regimen in children with primary hemophagocytic lymphohistiocytosis.
    Ge J; Zhang Q; Ma H; Wang D; Zhao Y; Zhu T; Wang W; Zhou C; Wei A; Lian H; Qin M; Yang J; Li Z; Wang T; Zhang R
    Haematologica; 2024 Feb; 109(2):458-465. PubMed ID: 37470145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Therapeutic Approaches to Familial HLH (Emapalumab in FHL).
    Merli P; Algeri M; Gaspari S; Locatelli F
    Front Immunol; 2020; 11():608492. PubMed ID: 33424859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The clinical characteristics of adult hemophagocytic lymphohistiocytosis treated with haploidentical donor hematopoietic stem cell transplantation].
    Fu L; Wei N; Wang JS; Wu L; Wang YN; Huang DY; Liu JL; Wang Z
    Zhonghua Nei Ke Za Zhi; 2017 Apr; 56(4):273-278. PubMed ID: 28355720
    [No Abstract]   [Full Text] [Related]  

  • 7. Genetic and clinical characteristics of primary hemophagocytic lymphohistiocytosis in children.
    Zhao C; Zhang Q; Zhang R; Lian H; Ma H; Zhao X; Li Z
    Ann Hematol; 2024 Jan; 103(1):17-28. PubMed ID: 37851074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical study of haploidentical hematopoietic stem cell transplantation on 15 cases of adult-onset primary hemophagocytic lymphohistiocytosis].
    Wang YN; Wang JS; Wei N; Wu L; Jin ZL; Wang Z
    Zhonghua Xue Ye Xue Za Zhi; 2020 Jun; 41(6):511-516. PubMed ID: 32654467
    [No Abstract]   [Full Text] [Related]  

  • 9. Allogeneic hematopoietic stem-cell transplantation for adult and adolescent hemophagocytic lymphohistiocytosis: a single center analysis.
    Fu L; Wang J; Wei N; Wu L; Wang Y; Huang W; Zhang J; Liu J; Wang Z
    Int J Hematol; 2016 Nov; 104(5):628-635. PubMed ID: 27431489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of allogeneic hematopoietic stem cell transplantation for primary hemophagocytic lymphohistiocytosis in adults.
    He L; Wang Y; Suolitiken D; Zhang R; Liu M; Hua Z; Yao S; Zou H; Wang Z
    Hematol Oncol; 2022 Aug; 40(3):390-399. PubMed ID: 35526261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PEG-aspargase and DEP regimen combination therapy for refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
    Wang J; Wang Y; Wu L; Zhang J; Lai W; Wang Z
    J Hematol Oncol; 2016 Sep; 9(1):84. PubMed ID: 27613189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recommendations for the Use of Etoposide-Based Therapy and Bone Marrow Transplantation for the Treatment of HLH: Consensus Statements by the HLH Steering Committee of the Histiocyte Society.
    Ehl S; Astigarraga I; von Bahr Greenwood T; Hines M; Horne A; Ishii E; Janka G; Jordan MB; La Rosée P; Lehmberg K; Machowicz R; Nichols KE; Sieni E; Wang Z; Henter JI
    J Allergy Clin Immunol Pract; 2018; 6(5):1508-1517. PubMed ID: 30201097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemophagocytic lymphohistiocytosis is a sign of poor outcome in pediatric Epstein-Barr virus-associated post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation.
    Ali S; AlThubaiti S; Renzi S; Krueger J; Chiang KY; Naqvi A; Schechter T; Punnett A; Ali M
    Pediatr Transplant; 2019 Feb; 23(1):e13319. PubMed ID: 30417487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emapalumab for adult and pediatric patients with hemophagocytic lymphohistiocytosis.
    Garonzi C; Chinello M; Cesaro S
    Expert Rev Clin Pharmacol; 2021 May; 14(5):527-534. PubMed ID: 33686916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-world treatment patterns and outcomes in patients with primary hemophagocytic lymphohistiocytosis treated with emapalumab.
    Chandrakasan S; Jordan MB; Baker A; Behrens EM; Bhatla D; Chien M; Eckstein OS; Henry MM; Hermiston ML; Hinson AP; Leiding JW; Oladapo A; Patel SA; Pednekar P; Ray AK; Dávila Saldaña B; Sarangi SN; Walkovich KJ; Yee JD; Zoref-Lorenz A; Allen CE
    Blood Adv; 2024 May; 8(9):2248-2258. PubMed ID: 38429096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Review of Current and Emerging Therapeutic Options for Hemophagocytic Lymphohistiocytosis.
    Summerlin J; Wells DA; Anderson MK; Halford Z
    Ann Pharmacother; 2023 Jul; 57(7):867-879. PubMed ID: 36349896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic and Nodular Hyperinflammation in a Patient with Refractory Familial Hemophagocytic Lymphohistiocytosis 2.
    Segal JE; Daley JD; Barnum JL; Salgado CM; Reyes-Mugica M; Schneider C; Gumus S; Thakrar D; Allen SW; Canna SW
    J Clin Immunol; 2021 Jul; 41(5):987-991. PubMed ID: 33570715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The outcome of hematopoietic stem cell transplantation in Korean children with hemophagocytic lymphohistiocytosis.
    Yoon HS; Im HJ; Moon HN; Lee JH; Kim HJ; Yoo KH; Sung KW; Koo HH; Kang HJ; Shin HY; Ahn HS; Cho B; Kim HK; Lyu CJ; Lee MJ; Kook H; Hwang TJ; Seo JJ
    Pediatr Transplant; 2010 Sep; 14(6):735-40. PubMed ID: 20113424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stem cell transplantation for children with hemophagocytic lymphohistiocytosis: results from the HLH-2004 study.
    Bergsten E; Horne A; Hed Myrberg I; Aricó M; Astigarraga I; Ishii E; Janka G; Ladisch S; Lehmberg K; McClain KL; Minkov M; Nanduri V; Rosso DA; Sieni E; Winiarski J; Henter JI
    Blood Adv; 2020 Aug; 4(15):3754-3766. PubMed ID: 32780845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematopoietic Stem Cell Transplantation for XIAP Deficiency in Japan.
    Ono S; Okano T; Hoshino A; Yanagimachi M; Hamamoto K; Nakazawa Y; Imamura T; Onuma M; Niizuma H; Sasahara Y; Tsujimoto H; Wada T; Kunisaki R; Takagi M; Imai K; Morio T; Kanegane H
    J Clin Immunol; 2017 Jan; 37(1):85-91. PubMed ID: 27815752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.